Skip to main content

RETRACTION article

Front. Toxicol., 25 November 2024
Sec. Clinical Toxicology
This article is part of the Research Topic Magnetic Resonance Imaging Contrast Agents: The Safety of Gadolinium View all 4 articles

Retraction: Near-cure in patients with Gadolinium deposition disease undergoing intravenous DTPA chelation

A Retraction of the Original Research
Near-cure in patients with Gadolinium deposition disease undergoing intravenous DTPA chelation

by Semelka RC and Ramalho M (2024) Front. Toxicol. 6:1371131. doi: 10.3389/ftox.2024.1371131

The publisher retracts the 25 July 2024 article cited above.

Following publication, the publisher found evidence of multiple undisclosed conflicts of interest that undermined the integrity of the peer review process. As the scientific integrity of the article cannot be guaranteed, and in adherence to the recommendations of the Committee on Publication Ethics (COPE), the article is retracted.

This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher. The authors do not agree to this retraction.

Citation: Frontiers Editorial Office (2024) Retraction: Near-cure in patients with Gadolinium deposition disease undergoing intravenous DTPA chelation. Front. Toxicol. 6:1528757. doi: 10.3389/ftox.2024.1528757

Received: 15 November 2024; Accepted: 15 November 2024;
Published: 25 November 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.